Medindia

X

Clarification and Apology to the American Academy of Sleep Medicine Regarding March 16 Press Release by Itamar Medical

Sunday, March 19, 2017 Drug News J E 4
Advertisement

CAESAREA, Israel, March 19, 2017 /PRNewswire/ --

Itamar Medical Ltd. (TASE: ITMR) wishes to clarify its recent press release, "An Important Recognition in the US Market for the WatchPAT™ Device" from March 16th.

Certain language in the press release mistakenly implies that the new AASM clinical practice guideline formally endorses Itamar Medical's WatchPAT™ product. In fact, the new AASM guideline was solely referring to the Peripheral Arterial Tonometry (PAT) technology as technically adequate based on evidence, and not to a specific product or device manufacturer.

Itamar Medical wishes to publicly and sincerely apologize for any potential misunderstanding and inconvenience this caused to the AASM, its members or their patients. 

About Itamar Medical Ltd. 

Itamar Medical Ltd. is a publicly traded medical device company (TASE:ITMR) that develops and markets innovative diagnostic and therapy solutions for sleep breathing disorders and cardiovascular conditions.

Contact:  Gilad Glick Chief Executive Officer and President T: +972-4-6177000  info@itamar-medical.com

SOURCE Itamar Medical Ltd

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Uninterrupted Pradaxa® (dabigatran etexilate mesyl...
S
New analysis shows Novartis Entresto improves glyc...